These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20818894)

  • 21. Current and emerging biologics for the treatment of hereditary angioedema.
    Perego F; Wu MA; Valerieva A; Caccia S; Suffritti C; Zanichelli A; Bergamaschini L; Cicardi M
    Expert Opin Biol Ther; 2019 Jun; 19(6):517-526. PubMed ID: 30912460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of C1 inhibitor concentrate in hereditary angioedema with C1 inhibitor deficiency: Analysis in a French cohort.
    Belbézier A; Boccon-Gibod I; Thanh AD; Fain O; Bouillet L;
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):506-508. PubMed ID: 29964227
    [No Abstract]   [Full Text] [Related]  

  • 23. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.
    Bernstein JA; Moellman JJ
    Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema.
    Frank MM
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S23-9. PubMed ID: 18220149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.
    Cicardi M; Bork K; Caballero T; Craig T; Li HH; Longhurst H; Reshef A; Zuraw B;
    Allergy; 2012 Feb; 67(2):147-57. PubMed ID: 22126399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].
    Muller Y; Harr T
    Rev Med Suisse; 2016 Jan; 12(500):11-2. PubMed ID: 26946694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies.
    Bernstein JA
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S41-6. PubMed ID: 18220151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological therapy in hereditary angioedema: transformation of a rare disease.
    Longhurst H; Farkas H
    Expert Opin Biol Ther; 2020 May; 20(5):493-501. PubMed ID: 31994957
    [No Abstract]   [Full Text] [Related]  

  • 29. Update on therapeutic developments for hereditary angioedema.
    Christiansen SC; Zuraw BL
    Allergy Asthma Proc; 2009; 30(5):500-5. PubMed ID: 19843404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current treatment of hereditary angioedema: An update on clinical studies.
    Banerji A
    Allergy Asthma Proc; 2010; 31(5):398-406. PubMed ID: 20929607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of novel therapies for acute hereditary angioedema.
    Firszt R; Frank MM
    Am J Clin Dermatol; 2010 Dec; 11(6):383-8. PubMed ID: 20866113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hereditary angioedema--treatment].
    Muszyńska A; Fal AM
    Pol Merkur Lekarski; 2008 Jul; 25(145):94-6. PubMed ID: 18839625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrate.
    Gorman PJ
    Can Fam Physician; 2008 Mar; 54(3):365-6. PubMed ID: 18337530
    [No Abstract]   [Full Text] [Related]  

  • 34. Update on the acute treatment of hereditary angioedema.
    Riedl MA
    Allergy Asthma Proc; 2011; 32(1):11-6. PubMed ID: 21262093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HAE update: determining optimal patient specific therapy.
    Gower RG
    Allergy Asthma Proc; 2013; 34(1):7-12. PubMed ID: 23406928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients.
    Farkas H
    Paediatr Drugs; 2018 Apr; 20(2):135-151. PubMed ID: 29214395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced acute hereditary angioedema: a life-threatening condition.
    Nagler R; Muska E; Laster Z
    J Oral Maxillofac Surg; 2008 Jun; 66(6):1287-9. PubMed ID: 18486799
    [No Abstract]   [Full Text] [Related]  

  • 38. Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.
    Prescrire Int; 2010 Nov; 19(110):245-7. PubMed ID: 21284353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Icatibant as acute treatment for hereditary angioedema in adults.
    Farkas H
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):779-88. PubMed ID: 27123689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema.
    Castaldo AJ; Jervelund C; Corcoran D; Boysen HB; Christiansen SC; Zuraw BL
    Allergy Asthma Proc; 2021 Mar; 42(2):108-117. PubMed ID: 33581742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.